| Application no. and date | 09793546.4 (espacenet) (Federated) (European Patent Register), 20091221 | | Patent/reg. no. and date | DK/EP 2379069, 20150304 | | Publication date | 20111026 | | Priority no. and date | US 139673 P, 20081222, EP 09167209, 20090804 | | EP pub. no. and date |
EP 2379069 20111026 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | V1505-008-DK | | Inventor | LEGANGNEUX, Eric, c/o Novartis Pharma AG
Postfach
CH-4002 Basel, CH | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/192 (2006.01) , A61K 31/397 (2006.01) , A61K 31/401 (2006.01) , A61K 31/445 (2006.01) , A61P 37/00 (2006.01) , A61P 37/06 (2006.01) | | Title | Doseringsplan for en S1P-receptoragonist | | Int. application no. | EP2009067618 | | Int. publication no. | WO2010072703 | | Related patent (certificate) | CA 2020 00026 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
